These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9573078)

  • 21. Intranasal immunization with recombinant outer membrane protein P6 induces specific immune responses against nontypeable Haemophilus influenzae.
    Hotomi M; Yamanaka N; Shimada J; Suzumoto M; Ikeda Y; Sakai A; Arai J; Green B
    Int J Pediatr Otorhinolaryngol; 2002 Sep; 65(2):109-16. PubMed ID: 12176180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A bacterial vaccine polypeptide protective against nontypable Haemophilus influenzae.
    Whitby PW; Morton DJ; Mussa HJ; Mirea L; Stull TL
    Vaccine; 2020 Mar; 38(14):2960-2970. PubMed ID: 32111525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Protein E-PilA Fusion Protein Shows Vaccine Potential against Nontypeable Haemophilus influenzae in Mice and Chinchillas.
    Ysebaert C; Denoël P; Weynants V; Bakaletz LO; Novotny LA; Godfroid F; Hermand P
    Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31109946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent otitis media with non-typable Haemophilus influenzae: the role of serum bactericidal antibody.
    Bernstein JM; Faden HS; Loos BG; Murphy TF; Ogra PL
    Int J Pediatr Otorhinolaryngol; 1992 Jan; 23(1):1-13. PubMed ID: 1592547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intranasal immunization with outer membrane protein P6 and cholera toxin induces specific sinus mucosal immunity and enhances sinus clearance of nontypeable Haemophilus influenzae.
    Sabirov A; Kodama S; Sabirova N; Mogi G; Suzuki M
    Vaccine; 2004 Aug; 22(23-24):3112-21. PubMed ID: 15297063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection against development of otitis media induced by nontypeable Haemophilus influenzae by both active and passive immunization in a chinchilla model of virus-bacterium superinfection.
    Bakaletz LO; Kennedy BJ; Novotny LA; Duquesne G; Cohen J; Lobet Y
    Infect Immun; 1999 Jun; 67(6):2746-62. PubMed ID: 10338477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody response to Haemophilus influenzae outer membrane protein D, P6, and OMP26 after nasopharyngeal colonization and acute otitis media in children.
    Pichichero ME; Kaur R; Casey JR; Sabirov A; Khan MN; Almudevar A
    Vaccine; 2010 Oct; 28(44):7184-92. PubMed ID: 20800701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum antibody response to three non-typeable Haemophilus influenzae outer membrane proteins during acute otitis media and nasopharyngeal colonization in otitis prone and non-otitis prone children.
    Kaur R; Casey JR; Pichichero ME
    Vaccine; 2011 Jan; 29(5):1023-8. PubMed ID: 21129398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization with HMW1 and HMW2 adhesins protects against colonization by heterologous strains of nontypeable
    Kadry NA; Porsch EA; Shen H; St Geme JW
    Proc Natl Acad Sci U S A; 2021 Aug; 118(32):. PubMed ID: 34344825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphorylcholine decreases early inflammation and promotes the establishment of stable biofilm communities of nontypeable Haemophilus influenzae strain 86-028NP in a chinchilla model of otitis media.
    Hong W; Mason K; Jurcisek J; Novotny L; Bakaletz LO; Swords WE
    Infect Immun; 2007 Feb; 75(2):958-65. PubMed ID: 17130253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast-feeding is associated with a reduced frequency of acute otitis media and high serum antibody levels against NTHi and outer membrane protein vaccine antigen candidate P6.
    Sabirov A; Casey JR; Murphy TF; Pichichero ME
    Pediatr Res; 2009 Nov; 66(5):565-70. PubMed ID: 19581824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Th17 cells contribute to nontypeable Haemophilus influenzae-specific protective immunity induced by nasal vaccination with P6 outer membrane protein and α-galactosylceramide.
    Noda K; Kodama S; Umemoto S; Nomi N; Hirano T; Suzuki M
    Microbiol Immunol; 2011 Aug; 55(8):574-81. PubMed ID: 21605159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intranasal immunization with a lipooligosaccharide-based conjugate vaccine from nontypeable Haemophilus influenzae enhances bacterial clearance in mouse nasopharynx.
    Hirano T; Hou Y; Jiao X; Gu XX
    FEMS Immunol Med Microbiol; 2003 Jan; 35(1):1-10. PubMed ID: 12589951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single nasal dose of fms-like tyrosine kinase receptor-3 ligand, but not peritoneal application, enhances nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx.
    Kodama S; Hirano T; Noda K; Abe N; Suzuki M
    Vaccine; 2010 Mar; 28(13):2510-6. PubMed ID: 20117272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum Concentrations of Antibodies against Outer Membrane Protein P6, Protein D, and T- and B-Cell Combined Antigenic Epitopes of Nontypeable Haemophilus influenzae in Children and Adults of Different Ages.
    Hua CZ; Hu WL; Shang SQ; Li JP; Hong LQ; Yan J
    Clin Vaccine Immunol; 2016 Feb; 23(2):155-61. PubMed ID: 26677200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bactericidal antibody response against P6, protein D, and OMP26 of nontypeable Haemophilus influenzae after acute otitis media in otitis-prone children.
    Khan MN; Kaur R; Pichichero ME
    FEMS Immunol Med Microbiol; 2012 Aug; 65(3):439-47. PubMed ID: 22463053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529.
    Mason KW; Zhu D; Scheuer CA; McMichael JC; Zlotnick GW; Green BA
    Vaccine; 2004 Sep; 22(25-26):3449-56. PubMed ID: 15308371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunization with high-molecular-weight adhesion proteins of nontypeable Haemophilus influenzae modifies experimental otitis media in chinchillas.
    Barenkamp SJ
    Infect Immun; 1996 Apr; 64(4):1246-51. PubMed ID: 8606086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and immunogenicity evaluation of C-HapS-P6 fusion protein vaccine against nontypeable Haemophilus influenzae in mice.
    Hu N; Li W; Zhao Z; Chang Y; Wang C; Zhang Y
    Int J Med Microbiol; 2024 Mar; 314():151616. PubMed ID: 38461565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of linezolid in experimental otitis media.
    Pelton SI; Figueira M; Albut R; Stalker D
    Antimicrob Agents Chemother; 2000 Mar; 44(3):654-7. PubMed ID: 10681334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.